This protocol is judged by an institutional evaluate board, an independent team that opinions any clinical trials involving humans. If a study consists of a Schedule I drug, after the board approves the protocol as ethical, the scientists have to make an application for an investigational new drug (IND) range through the FDA.While using the doses p… Read More